Clinical Trial Update: A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for YL202 in patients with non-small cell lung cancer and breast cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• YL202

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Non Small Cell Lung Cancer, Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING